Laboratory experiments were carried out to determine the bioeffects of an isolate of entomopthogenic fungi Beauveria bassiana (Bals.) and Biofly a commercial product of B. bassiana, on the 1 st instar larvae of mushroom fly, Bradysia ocellaris (coms). The bioactivity of B. bassiana was tested, using five concentrations of B. bassiana on some biological criteria of the mushroom fly, by calculating LC50 values after three and seven days of treatment. Results indicated that the mortality rates percentage increased with the increase of the concentrations used and the period after treatment. The highest percentage of mortality occurred within the first seven days following treatment. Statistical analysis of the obtained larval-pupal and adults period and weight revealed significant differences between treated and nontreated insects.
INTRODUCTION
In recent years, an increasing consumer demand for commercial mushroom products, as natural healthy foods has raised concerns about problems in mushroom production. Mushroom flies proved to be a serious pest facing mushroom growers (Finley et al 1984; Ishitani, et al 1997; Jess and Kilpatrick, 2000) . The existing control measures against the fly still rely on chemical insecticides, which are not always appropriate. The use of pathogens may offer an environmentally sound method for the management of insect pests. Hyphomycete fungi are the most promising candidates (Prior, 1990).
Entomopathogenic fungi have been intensively studied as potential microbial insecticides (Gillespie 1988; Ferron et al 1991; Malsam et al 1998).
Beauveria spp. has been investigated because of their ability to infect a wide range of insects. There are more than 400 species recorded as entomopathogenic fungi, from which only about 20 species have the potential to be used in microbial control of insect pests (Zimmerman, 1986 ).
The present work was carried out with the endeavor of evaluating the bioassay of Beauveria bassiana against the mushroom fly Bradysia ocellaris and to evaluate the bioactivity effect of Beauveria bassiana on some biological criteria of mushroom fly B. ocellaris.
MATERIALS AND METHODS

Rearing mushroom fly
Mushroom fly B. ocellaris was reared under laboratory condition at 23±1 ‫ه‬ C in ventilated plastic boxes (28×16×9 cm) filled with peat to a depth of about 5 cm. About 10 ml of water was mixed into the peat so that the mixture will remain moist to the touch and 1g of wheat was distributed over the surface of peat as food source for the larvae. Adult mushroom flies B. ocellaris were put into the boxes and an additional 1g of wheat grain was added every 3-4 days together with a cotton plug soaked in a 20% glucose to boost the number of eggs laid by females (Gouge 1994).
Two ELISA dishes were used for each treatment; every well of the bottom ELISA dish contained one wheat grain covered with spawn and one larvae of Bradysia ocellaris . The dishes were treated with different concentrations of B. bassiana (10 2 , 10 3 , 10 4 , 10 5 , 10 6 ) conidia/ml, control treatment was treated with 0.1%Tween alone. In the well of the upper dish, a piece of cotton moistened with similar concentrations of B. bassiana and with sterilized water + 0.1%Tween 80 in the control treatment. Dishes were then put inside moist boxes containing moistened filter paper. The dishes were incubated at 23± 1 ‫ه‬ C , 70 ± 5 % RH and 24h (dark). Mortality was recorded daily for about 14 days. Dead larvae were removed and maintained in a moist chamber to allow for fructification of the relevant fungus
Bioassay experiments
In this study, the entomopathogenic fungus B. bassiana, (S1), isolated from adults of Eurygaster integriceps pest and (Biofly), a commercial product of B.bassiana, were assayed for their bioinsecticidal activities against 1 st instar larvae of the B. ocellaris. The first isolate was grown and maintained on Potato Dextrose Antibiotic Agar (PDAA) and incubated in the dark for 20 days at 25±1°C
. for the actual bioassay, conidial suspensions of each of the isolates were prepared by scraping conidia from the surface of 20 days old cultures in 0.1% Tween 80. The suspension was diluted in sterilized water + 0.1% Tween 80 to get suspensions ranging from 1×10 2 to 1×10 6 conidia / ml. A total of 10 ml suspension was prepared for each dilution.
Larvae treatment
The experiments were carried out under laboratory conditions of 23±1 o C and 80±5 RH. and 10 6 conidia/ml were used. In all experiments percentage mortality was calculated after 3, 5, 7, 10, and 14 days. Percentage of mortality of each treatment was corrected use using Abbott , s formula (Abbott, 1925). The percentages of mortality were statistically computed according to (Finney, 1952) and computed mortality percentages were plotted versus log concentrations on logarithmic probit paper to obtain the corresponding regression mortality lines. The concentrations required to give 50% mortality (LC50) were estimated from the established regression lines (Jyoti and Brewer, 1999). Each concentration test included 3 replicates each of 24 larvae (72 larvae/ concentration, 432 larvae /treatment).
Biological studies: 1 st instar larvae were treated in the same manner with the determined LC50 to study the effect of the entomopathogenic fungus B. bassiana and Biofly on certain biological aspects of the mushroom fly. Five replicates of 1 st instar larvae (40 larvae/replicate) were used for each compound. Larval and pupal mortalities, their durations, weight and moth emergence were recorded. The experiments were carried out under laboratory conditions of 23±1C o and 80±5 RH.
Statistical analysis
ANOVA was performed using SAS software program. Table (1) show the mortality percentage of 1 st instar larvae of mushroom fly after treatment with different concentrations of B. bassiana. The tested B. bassiana had a great efficacy against mushroom fly larvae. Also results indicate that the mortality rates increased with the increase of the concentration used and the period after treatment.
RESULTS AND DISCUSSION
Bioeffect of an isolates of the entomopathogenic fungus B. bassiana and Biofly on mushroom fly B. ocellaris larvae
Results in
The corrected mortality percentages after 3 days for S1 isolate treatment ranged from 8.9% using the lowest concentration (10 2 conidia/ml), to 38.82% using the highest concentration (10 6 conidia/ml). As treatment, the corrected percentages of mortality ranged from 4.3 to 29.34 % for the lowest and highest concentrations, respectively for Biofly. These percentages increased to 50.6, and 19.06% after 7 days of treatment for S1 and bio fly, respectively. In contrast, the mortality percentages recorded for the highest concentration (10 6 conidia/ml) were 82.06, 64.61% after 7 days, for the treatment with S1 and bio fly) respectively. Also the highest cumulative mortality (85.06, 69.6%) was recorded after 14 days of treatment with 10 6 conidia /ml of (S1, biofly) respectively Table (1). The concentration mortality lines are graphically illustrated in Figs. (1 and 2) and showed a positive relationship between larval mortality and the concentrations used. It is worth mentioning that the highest percentage of mortality occurred within the first 7days following treatment, while Larval mortality was relatively lower after 10 days (Table 1) .
Effect of LC50 concentrations of an isolate of the entomopathogenic fungi B. bassiana and Biofly on larval, pupal and adult stages mortality of mushroom fly Bradysia ocellaris Table ( 2) show that the LC50 concentrations of the entomopathogenic B. bassiana and Biofly which killed 50% of the treated larvae (after 7 days of treatment) had great effects on larval-pupal periods and adult longevity. Statistical analysis of the obtained larval-pupal periods and pupal weight revealed significant differences between treated and non-treated insects. The larval, pupal periods and adult longevity were 11.2, 5, 6.1, days respectively (non-treated).Application of the entomopathogenic fungi B.bssiana and Biofly shortened larval and pupal development and adult longevity, which were 8. 
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